These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30468374)

  • 21. Yin and Yang: A disrupted skin microbiome and an aberrant host immune response in hidradenitis suppurativa.
    Schell SL; Schneider AM; Nelson AM
    Exp Dermatol; 2021 Oct; 30(10):1453-1470. PubMed ID: 34018644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review.
    Ruggiero A; Martora F; Picone V; Marano L; Fabbrocini G; Marasca C
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients.
    Scheinfeld N
    Dermatol Online J; 2013 Apr; 19(4):1. PubMed ID: 24021361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hidradenitis suppurativa: the role of deficient cutaneous innate immunity.
    Dréno B; Khammari A; Brocard A; Moyse D; Blouin E; Guillet G; Léonard F; Knol AC
    Arch Dermatol; 2012 Feb; 148(2):182-6. PubMed ID: 22004878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hidradenitis suppurativa: current views on epidemiology, pathogenesis, and pathophysiology.
    Micheletti RG
    Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S48-50. PubMed ID: 25188457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis and pharmacotherapy of Hidradenitis suppurativa.
    Nazary M; van der Zee HH; Prens EP; Folkerts G; Boer J
    Eur J Pharmacol; 2011 Dec; 672(1-3):1-8. PubMed ID: 21930119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid autoimmunity in patients with hidradenitis suppurativa: a case-control study.
    González-López MA; Hernández JL; Vilanova I; Mata C; López-Escobar M; González-Vela MC; López-Hoyos M; González-Gay MA; Blanco R
    Clin Exp Dermatol; 2017 Aug; 42(6):642-644. PubMed ID: 28589559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophil extracellular traps, B cells, and type I interferons contribute to immune dysregulation in hidradenitis suppurativa.
    Byrd AS; Carmona-Rivera C; O'Neil LJ; Carlucci PM; Cisar C; Rosenberg AZ; Kerns ML; Caffrey JA; Milner SM; Sacks JM; Aliu O; Broderick KP; Reichner JS; Miller LS; Kang S; Robinson WH; Okoye GA; Kaplan MJ
    Sci Transl Med; 2019 Sep; 11(508):. PubMed ID: 31484788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Endocrinological mechanisms in the pathophysiology of hidradenitis suppurativa].
    Nikolakis G; Karagiannidis I; Vaiopoulos AG; Becker M; Zouboulis CC
    Hautarzt; 2020 Oct; 71(10):762-771. PubMed ID: 32886132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beyond antibodies: B cells in Hidradenitis Suppurativa: Bystanders, contributors or therapeutic targets?
    Frew JW; Grand D; Navrazhina K; Krueger JG
    Exp Dermatol; 2020 May; 29(5):509-515. PubMed ID: 32145106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coexistence of Hidradenitis Suppurativa with Autoimmune Thyroiditis: Report of Three Cases.
    González-López MA; Blanco R; Mata C; López-Escobar M; Lacalle M; Consuegra G; González-Vela MC; González-Gay MA
    Dermatology; 2016; 232(2):162-4. PubMed ID: 26444851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should Hidradenitis Suppurativa Be Included in Dermatoses Showing Koebnerization? Is It Friction or Fiction?
    Boer J
    Dermatology; 2017; 233(1):47-52. PubMed ID: 28505620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prepubertal Hidradenitis suppurativa: Report of 2 clinical cases].
    Silva-Feistner M; Salomone C; Silva S; Vial-Letelier V
    Rev Chil Pediatr; 2016; 87(3):193-8. PubMed ID: 26613628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate lymphoid cell (ILC) subsets are enriched in the skin of patients with hidradenitis suppurativa.
    Petrasca A; Hambly R; Molloy O; Kearns S; Moran B; Smith CM; Hughes R; O'Donnell M; Zaborowski A; Winter D; Fletcher JM; Kirby B; Malara A
    PLoS One; 2023; 18(2):e0281688. PubMed ID: 36780439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa.
    Kelly G; Hughes R; McGarry T; van den Born M; Adamzik K; Fitzgerald R; Lawlor C; Tobin AM; Sweeney CM; Kirby B
    Br J Dermatol; 2015 Dec; 173(6):1431-9. PubMed ID: 26282467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mast cells in hidradenitis suppurativa: a clinicopathological study.
    List EK; Pascual JC; Zarchi K; Nürnberg BM; Jemec GBE
    Arch Dermatol Res; 2019 May; 311(4):331-335. PubMed ID: 30877368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis.
    Scheinfeld N
    Dermatol Online J; 2013 Jun; 19(6):18558. PubMed ID: 24011308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The psychosocial impact of hidradenitis suppurativa.
    Gooderham M; Papp K
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S19-22. PubMed ID: 26470609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hidradenitis suppurativa: a review with a focus on treatment data.
    Barlev D; Eisen DB; Alikhan A
    Skin Therapy Lett; 2015; 20(4):1-8. PubMed ID: 26382710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hidradenitis suppurativa: a review of cause and treatment.
    Yazdanyar S; Jemec GB
    Curr Opin Infect Dis; 2011 Apr; 24(2):118-23. PubMed ID: 21192260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.